David T. Hagerty
2016
In 2016, David T. Hagerty earned a total compensation of $762.5K as Executive Vice President, Clinical Development at Conatus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $186,797 |
|---|---|
| Option Awards | $172,252 |
| Salary | $389,160 |
| Other | $14,338 |
| Total | $762,547 |
Hagerty received $389.2K in salary, accounting for 51% of the total pay in 2016.
Hagerty also received $186.8K in non-equity incentive plan, $172.3K in option awards and $14.3K in other compensation.
Rankings
In 2016, David T. Hagerty's compensation ranked 9,488th out of 14,075 executives tracked by ExecPay. In other words, Hagerty earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,488 out of 14,075 | 33rd |
Division Manufacturing | 3,675 out of 5,489 | 33rd |
Major group Chemicals And Allied Products | 1,271 out of 1,895 | 33rd |
Industry group Drugs | 1,010 out of 1,538 | 34th |
Industry Pharmaceutical Preparations | 794 out of 1,176 | 33rd |
Source: SEC filing on April 27, 2018.
Hagerty's colleagues
We found one more compensation record of an executive who worked with David T. Hagerty at Conatus Pharmaceuticals in 2016.
2016
Steven Mento
Conatus Pharmaceuticals